Updated quarterly (four times a year) to reflect market changes

Kalorama Information’s 30-Country IVD Market Atlas, 2025 provides a comprehensive analysis of the in vitro diagnostic (IVD) markets across 30 key countries, including the U.S., China, Germany, UK,  Saudi Arabia, India, UAE, France, Vietnam, and Turkey, among others. This in-depth report delivers detailed market sizing, forecasts for 2029 and 2030, and quarterly updates throughout 2025, ensuring timely insights into the evolving global IVD landscape.

Leveraging over two decades of market research expertise, Kalorama Information presents a country-level approach, offering granular estimates for critical IVD segments, including:

• Blood Bank Screening - Immunos
• Coagulation PT/Routine
• Critical Care (core lab)
• General Chemistries
• Hematology
• Histology
• Immunoassays – Micro
• Immunoassays - Non-Micro
• Microbiology – ID/AST
• Molecular - Other
• Molecular Bloodstream/HAI
• Molecular HIV & Hepatitis
• Molecular Respiratory
• Other POC
• POC Critical Care
• POC Fecal Occult
• POC Glucose (all)
• POC Infectious Disease (all)
• POC Pregnancy & Fertility
• Other IVD

The report captures key market drivers, including international developments, regulatory changes, mergers and acquisitions, and new product launches, providing essential intelligence for industry stakeholders. Unlike fragmented country-specific reports, Kalorama’s 30-Country IVD Market Atlas, 2025 consolidates these insights into a single, authoritative resource, aligning with its mission to deliver comprehensive and actionable market intelligence.

Subscribers gain access to the report’s quarterly updates via Kalorama’s Knowledge Center, ensuring they remain informed with the most up-to-date data for strategic decision-making in the dynamic global IVD market.